Synaptogenix

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Synaptogenix and other ETFs, options, and stocks.

About SNPX

Synaptogenix, Inc. operates as a biopharmaceutical company, which engages in the development of a product platform based upon a drug candidate called Bryostatin-1 used for the treatment of Alzheimer’s disease. The firm also evaluates potential therapeutic applications of Bryostatin-1 for other neurodegenerative or cognitive diseases and dysfunctions. 

CEO
Alan J. Tuchman
CEOAlan J. Tuchman
Employees
4
Employees4
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2012
Founded2012
Employees
4
Employees4

SNPX Key Statistics

Market cap
47.06M
Market cap47.06M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
47.00K
Average volume47.00K
High today
$7.06
High today$7.06
Low today
$6.66
Low today$6.66
Open price
$6.96
Open price$6.96
Volume
43.06K
Volume43.06K
52 Week high
$14.50
52 Week high$14.50
52 Week low
$3.79
52 Week low$3.79

SNPX Earnings

-$0.54
-$0.36
-$0.18
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 19, Pre-Market
ActualExpected Nov 19, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.